Abstract: Novel Expanded Safe Zone System for Treatment of Submental Fullness with ATX-101 (Deoxycholic Acid)
نویسندگان
چکیده
RESULTS: 264 responses were received. Averaged scores across the 10 survey patients produced a value for each appearance or personality trait. In 10 of 11 categories (symmetry, youthfulness, facial harmony, likeability, trustworthiness, confidence, femininity, attractiveness, approachability, and intelligence), the post-operative photo was significantly favorable compared to the preoperative photo (p<.00001). The pre-operative photo was rated higher only in aggressiveness (p<.001). The same scores were calculated for the controls; no statistically significant difference in any category was seen except confidence, where the right image was viewed as more confident (mean 4.19, p<.005). No significant difference was seen across gender or age groups.
منابع مشابه
Alopecia after injection of ATX-101 for reduction of submental fat
BAs: Bile acids DCA: deoxycholic acid FDA: Food and Drug Administration INTRODUCTION Bile acids (BAs) are endogenously produced cholesterol derivatives that are found predominantly in bile and play a key role in lipid digestion. The surfactant activity of BAs is responsible for fat emulsification and subsequent solubilization, a process that is requisite for intestinal lipid absorption. Deoxych...
متن کاملAbstract: Injection Adipocytolysis with ATX-101 (Deoxycholic Acid) for Body Contouring
INTRODUCTION: Deoxycholic acid currently approved only for minimally invasive treatment of submental fat. The effects of deoxycholic acid on fat need not be limited to submental fat and represents an opportunity to treat undesired fat in many other body parts.1 Injection lipolysis has the potential risks of skin loss/necrosis, hyperpigmentation, neovascular response, and contour irregularities....
متن کاملNoninvasive Submental Fat Compartment Treatment
BACKGROUND KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration-approved injectable drug for the reduction of submental fat. OBJECTIVES A literature review and discussion of the treatment of submental fat. RESULTS KYBELLA is a well-tolerated alternative for the treatment of submental fat. CONCLUSIONS KYBELLA is a safe an...
متن کاملEarly Experience in 100 Consecutive Patients With Injection Adipocytolysis for Neck Contouring With ATX-101 (Deoxycholic Acid)
BACKGROUND Deoxycholic acid (DCA) is approved for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat. OBJECTIVE To assess early treatment experience with DCA injection in a clinical practice setting. MATERIALS AND METHODS In this single-center, prospective, single-arm, observational study, 100 consecutive patients seeking to decrease subm...
متن کاملAbstract: Implantable Deferoxamine Facilitates Non-Vascularized Grafting in Irradiated Bone
1. Kythera Biopharmaceuticals I. Dermatologic and ophthalmic drugs advisory committee briefing document: ATX-101 (deoxycholic acid) injection. https:// www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM436604.pdf. Accessed February 26, 2017. 2. Dayan SH, Humphrey S, Jones DH, et al. Overview of ATX-101 (Deoxycholic Acid ...
متن کامل